Our current observation could provide important insight to understanding the controversial roles of TUSC3 in lung cancer metastasis and the specific roles of UPR and HRD1 regulation in TUSC3-deficient lung cancer, as an anti-cancer therapeutic strategy against NSCLC. This evidence concerns the gene SYVN1 and cancer.